BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Dietary prophage inducers and antimicrobials: toward landscaping the human gut microbiome. ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: Issue Pages: 1-14 Pub: 2020 Jan 13 Epub: 2020 Jan 13 Authors Boling L , Cuevas DA , Grasis JA , Kang HS , Knowles B , Levi K , Maughan H , McNair K , Rojas MI , Sanchez SE , Smurthwaite C , Rohwer F , |
|
|
Spices as Sustainable Food Preservatives: A Comprehensive Review of Their Antimicrobial Potential. ✅
Go to Publication ✅
Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 16 Issue 10 Pages: Pub: 2023 Oct 12 Epub: 2023 Oct 12 Authors Sulieman AME , Abdallah EM , Alanazi NA , Ed-Dra A , Jamal A , Idriss H , Alshammari AS , Shommo SAM , |
|
|
Eugenol, A Major Component of Clove Oil, Attenuates Adiposity, and Modulates Gut Microbiota in High-Fat Diet-Fed Mice. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 66 Issue 20 Pages: e2200387 Pub: 2022 Oct Epub: 2022 Sep 6 Authors Li M , Zhao Y , Wang Y , Geng R , Fang J , Kang SG , Huang K , Tong T , |
|
|
Eugenol, A Major Component of Clove Oil, Attenuates Adiposity, and Modulates Gut Microbiota in High-Fat Diet-Fed Mice. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 66 Issue 20 Pages: e2200387 Pub: 2022 Oct Epub: 2022 Sep 6 Authors Li M , Zhao Y , Wang Y , Geng R , Fang J , Kang SG , Huang K , Tong T , |
|
|
Eugenol, A Major Component of Clove Oil, Attenuates Adiposity, and Modulates Gut Microbiota in High-Fat Diet-Fed Mice. ✅
Go to Publication ✅
Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 66 Issue 20 Pages: e2200387 Pub: 2022 Oct Epub: 2022 Sep 6 Authors Li M , Zhao Y , Wang Y , Geng R , Fang J , Kang SG , Huang K , Tong T , |
|
|
Essential Oils and Sustainability: In Vitro Bioactivity Screening of Myristica fragrans Houtt. Post-Distillation By-Products. ✅
Go to Publication ✅
Plants (Basel, Switzerland) (Plants (Basel) ) Vol: 12 Issue 9 Pages: Pub: 2023 Apr 23 Epub: 2023 Apr 23 Authors Trifan A , Zengin G , Korona-Glowniak I , Skalicka-Wozniak K , Luca SV , |
|
|
Bactericidal and antioxidant effects of essential oils from Satureja montana L., Myristica fragrans H. and Cymbopogon flexuosus. ✅
Go to Publication ✅
Letters in applied microbiology (Lett Appl Microbiol ) Vol: 74 Issue 5 Pages: 741-751 Pub: 2022 May Epub: 2022 Feb 25 Authors Rezende DADCS , Oliveira CD , Batista LR , Ferreira VRF , Brandão RM , Caetano ARS , Alves MVP , Cardoso MG , |
|
|
Phyto-chemical and biological activity of Myristica fragrans, an ayurvedic medicinal plant in Southern India and its ingredient analysis. ✅
Go to Publication ✅
Saudi journal of biological sciences (Saudi J Biol Sci ) Vol: 29 Issue 5 Pages: 3815-3821 Pub: 2022 May Epub: 2022 Mar 14 Authors Al-Qahtani WH , Dinakarkumar Y , Arokiyaraj S , Saravanakumar V , Rajabathar JR , Arjun K , Gayathri PK , Nelson Appaturi J , |
|
|
Sialidase inhibitory activity of diarylnonanoid and neolignan compounds extracted from the seeds of Myristica fragrans. ✅
Go to Publication ✅
Bioorganic & medicinal chemistry letters (Bioorg Med Chem Lett ) Vol: 27 Issue 14 Pages: 3060-3064 Pub: 2017 Jul 15 Epub: 2017 May 18 Authors Park JY , Hwan Lim S , Ram Kim B , Jae Jeong H , Kwon HJ , Song GY , Bae Ryu Y , Song Lee W , |
|
|
Antibacterial Activity of Myristica fragrans against Oral Pathogens. ✅
Go to Publication ✅
Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2012 Issue Pages: 825362 Pub: 2012 Epub: 2012 Aug 28 Authors Shafiei Z , Shuhairi NN , Md Fazly Shah Yap N , Harry Sibungkil CA , Latip J , |
|
|
Antimicrobial, synergistic and antibiofilm activities of Myristica fragrans Houtt. Bioactive compounds and their derivatives. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 15 Issue 1 Pages: 33041 Pub: 2025 Sep 26 Epub: 2025 Sep 26 Authors Kaur V , Kaushal S , Kalia A , Jangra R , Sharma P , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
